Abstract 1877P
Background
After completion of curative cancer treatment patients enter the re-entry phase, which is characterized by the difficult task to pick up life again. In the re-entry patients face existential concerns, besides physical and psychosocial concerns. Finding meaning and purpose in this new situation may help in dealing with existential concerns. More insight is needed in the existential concerns and the meaning-making process in order to support patients in the re-entry phase.
Methods
We conducted 6 focus groups with 16 patients (5 patients with melanoma and 11 with breast cancer) during the re-entry phase, defined as the point from completion of treatment (after surgical treatment and adjuvant systemic treatment, except for hormonal therapy) up to 18 months in remission. A thematic content analysis was performed by two researchers.
Results
In general, patients experienced existential concerns regarding their worldview, inner posture, values and the future. In addition, patients with melanoma struggled with trust and responsibility for their health; patients with breast cancer struggled with relationships and identity. Outcomes of the meaning-making process identified were: meaning is affected and gives distress, existing sources of meaning are helpful, search for meaning or new meaning has been found. These outcomes were found at the beginning as well as further into the re-entry, however during the re-entry the focus of the meaning-making process shifted from the disease to (picking up) life.
Conclusions
The transition from being a patient to picking up daily life in the re-entry phase involves dealing with existential concerns causing distress. Patients use existing sources of meaning, search for new meaning or have found new meaning in order to deal with these existential concerns and distress. A meaning-centered intervention increasing patients awareness of their personal sources of meaning might strengthen their meaning-making process and can help in dealing with existential concerns.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
A. Visser and L. Post.
Funding
Novartis b.v.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1614P - Integrated palliative care for patients referred for Chimeric Antigen Receptor T-cell (CAR-T) therapy: A service evaluation
Presenter: Rebekah Williams
Session: Poster session 05
1615P - Investigation of status of lung cancer palliative care management and concept and practice in Chinese medical providers
Presenter: Liling Ma
Session: Poster session 05
1845P - Exclusion of patients with psychiatric disorders from early phase oncology trials: A limited access to innovation?
Presenter: Paul Matte
Session: Poster session 05
1846P - The impact of newly diagnosed early breast cancer on distress, perception of health and psychologic resilience
Presenter: Anuska Budisavljevic
Session: Poster session 05
1847P - Monitoring of psychological state and quality of life during Simonton-training for oncologic patients
Presenter: Petra Harasztosi
Session: Poster session 05
1849P - Use of antipsychotic drugs during radiotherapy in adult cancer patients in Korea: The nationwide retrospective cohort study based on the health insurance review and assessment service database
Presenter: JIN HWA CHOI
Session: Poster session 05
1851P - Psychological well-being of patients with colorectal cancer during the third wave of the COVID-19 pandemic: Results from cohort II of the PICO-SM study
Presenter: Konstantinos Kamposioras
Session: Poster session 05
1852P - Mental health among Tunisian oncologists
Presenter: nefzi issaad
Session: Poster session 05
1853P - Effect of logotherapy on anxiety in patients with cancer: A systematic review and meta-analysis
Presenter: Douglas Barroso
Session: Poster session 05
1854P - The role of “1 minute” time perception in evaluating depression and anxiety in cancer patients receiving chemotherapy
Presenter: Sait Kitaplı
Session: Poster session 05